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The type specific-M protein is associated with the pathogenicity of/3-hemo- 
lyric streptococci (1-3). In addition, particular types of streptococci, and con- 
sequently particular M protein antigens, are associated with post streptococcal 
glomerulonephritis (4). Because of the apparent importance of this antigen in 
streptococcal infections and its non-suppurative complications, it was thought 
that investigation of the properties of the immune response to M protein might 
be of value in elucidating the pathogenesis of streptococcal disease. 
None of the presently available tests of anti-M protein activity measure the 
initial antigen-antibody  interaction, but rather they all depend upon secondarily 
related phenomena such as precipitation  (5),  agglutination (6),  complement 
fixation (7),  mouse protection  (8),  and opsinizing properties  (9).  These sec- 
ondary phenomena are  not necessary consequences of the primary antigen- 
antibody interaction, so that type-specific antibody from a  given antiserum 
may escape detection if it is not capable of manifesting itself in the form of one 
or more of the secondary reactions mentioned above. In order to circumvent 
this difficulty and to better study the initial antigen-antibody interaction be- 
tween M  protein and its antibody, a test of primary binding capacity of anti- 
serum has been employed. This test utilized as antigen a purified I131-1abeled 
type 12 acid extract which was soluble in 40  per cent saturated ammonium 
sulfate (I* M12). Gamma globulin and globulin-I* M12 complexes are insoluble 
at this concentration of ammonium sulfate, so that it was possible to use the 
differential precipitation of radioactivity in the presence of type 12 immune 
serum as compared with normal serum and immune serum directed against 
other types of streptococci as a measure of the binding between I* MI~ and its 
antibody. In addition, some information regarding the quality of this bond was 
obtained by measuring the dissociation of I* Mx2-anti Mx2 complexes as a func- 
tion of time. 
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Materials and Methods 
Antigens.-- 
(a)  Bea~-killed organisms: Cultures of 3-hemolytic streptococci  I  were stored at  -20°C in 
tubes containing Dlfco Todd-Hewitt broth and 3 per cent whole rabbit blood.  When ready 
for use, a  tube was thawed and added to 4.5 liter quantities of Todd-Hewitt broth.  Eighteen 
hour cultures were heated at 56°C for one hour and the cells harvested by centrlfugation and 
kept at 4°C, merthiolate 1:10,000 was added as a preservative. Cells were used in this state 
for one month without detectable loss of M protein activity. The quantity of organisms used 
for each experiment was standardized turbidimetrically with a Bausch and Lomb colorimeter 
and was later correlated to the dry weight obtained from an aliquot of the same concentration 
of organism. The range of organisms used varied from 12 to 0.4 mg dry weight and will  be 
indicated for each experiment. 
(b)  I* M12 antigen: A crude acid extract containing M  protein was prepared from  a  type 
12/~-hemolytic streptococcus according to the method described by Lancefield (5). The crude 
extract was fractionated twice with 60 per cent saturated ammonium sulfate  (60 per cent 
SAS) at 4°C, and the resultant precipitate was brought into solution with isotonic saline and 
dialyzed free of ammonium sulfate. Ribonudease  2 at a final concentration of 0.001 mg/ml was 
added  to the fractionated extract, and this solution was allowed to incubate for 2 hours at 
37°C and then was dialyzed at 4°C for 2 days in .01 ~s phosphate buffer pH 8.0 (10). Nitrogen 
determinations on the ribonudease treated  M12 extracts were performed by means of the 
micro-Kjeldahl method of Launi eta/.  (11). One milliliter of this semi-purified M12 extract 
containing 420 3, N  was labeled according to the method of Talmage eta/.  (12)  using 35 mc 
1131 in the procedure.  After dialysis to dispose of non-protein bound 1  lm,  the solution was 
incubated overnight with  a  high  titered  antiserum prepared  against  several  heterologous 
types of/~-hemolytic streptococci.  Saturated ammonium sulfate was  then added  to a  final 
concentration of 40 per cent and after centrifugation the resultant precipitate  was discarded. 
The latter procedure accomplished two purposes: (1)  It cleared the antigen of that portion 
which was not soluble in 40 per cent saturated ammonium sulfate.  (2)  It removed most of 
the antigen molecules capable of binding with antibodies directed against heterologous types 
of streptococci. The iodinated antigen remaining in the supernate was then treated with one 
per cent trichloracetic acid, and after the precipitate was resuspended in and dialyzed against 
saline it was used as a test antigen. Antigen dilutions were carried out in one per cent normal 
rabbit serum (1:100 NRS) toa concentrationof 0.002 to 0.0004 3' N/ml, theantigen  concentra- 
tion remaining constant for any given experiment. 
Antiserum.--Albino  New Zealand male rabbits weighing 2 to 3.5 kg were immunized with 
heat killed organisms, either intravenousiy according to the immunization schedule suggested 
by Lancefield (13)  or subcutaneously with 1 ml of an emulsion consisting of 1 part arlacel, 9 
parts bayol F, and 10 parts of a saline suspension containing 6 mg dry weight of heat-killed 
organisms/ml. In order to elicit a secondary response, a  similar bacteria and adjuvant emul- 
sion was  injected one month after primary stimulation and twice monthly  thereafter,  the 
adjuvant  injection being preceded  on  two  successive  days  by  subcutaneous  injections of 
bacteria in saline in the same dosage as used in the adjuvant administration. Bleedings were 
carried out between  17 and 30 days after primary stimulation and  7 days after secondary 
stimulation with bacteria in adjuvant. 
In the majority of experiments utilizing antiserum directed against heterologous strepto- 
cocci,  and unless otherwise noted,  an antiserum directed against six heterologous types of 
group A streptococci  3 was used to test the type specificity of the antigen. This was prepared 
1 Kindly supplied by Doctors R. Lancefield, A. I. Braude and A. Stock. 
2 Worthington Biochemical Corporation, Freehold, New Jersey. 
3 Type 1, 2,  14, 17, 33, Red Lake. HOWa_V~ ~r.  GS.~Y  673 
by culturing each type separately and then pooling them prior to the immunization of animals. 
Antiserum directed against single strains of heterologous streptococci was also prepared. 
All antisera were stored at  --20°C without preservative until the time of use. 
Absorption of Antisera.--Antisera were diluted 1:10 in borate buffer and absorbed  1 to 3 
times with a  volume of washed sedimented heterologous streptococcal cells equal to  1 to 2 
times the volume of undiluted sera. Absorption was usually carried out with a mixture of two 
or more heterologous strains of organisms, although no difference in the efficiency of absorption 
of non-type-specific antibody was demonstrated  when  comparison  between  separate  types 
and a  mixture of types was made.  Absorptions were carried out for 12 to  18 hours  at 4°C. 
There was never any detectable M protein solubilization over this period of time. 
D/luents.--Borate buffer (14) at pH 8.3,/~ -- 0.1, was routinely used for all dilutions. Anti- 
gen was diluted in a  1:100 normal rabbit serum: borate buffer solution. This was done to pro- 
vide sufficient protein carrier to prevent monolayering and denaturation of the antigen (15). 
All antisera were initially diluted  1:10 in borate buffer; the subsequent dilutions were made 
with 1:10 normal rabbit serum in borate buffer (1:10 NRS). The buffer served to control the 
pH of the reaction during the incubation of the antigen and the antibody, and when the anti- 
gen-antibody complexes were to be precipitated with ammonium sulfate, a final pH of 7.9 was 
maintained. The NRS diluent provided relatively constant amounts of protein over a  wide 
range of antiserum dilutions. In the ammonium sulfate technique, a constant concentration 
of globulins is important during the fractionation procedure, because the solubility of these 
serum proteins in ammonium sulfate varies with their concentration. 
Antigen Precipitating Capacity.--A variation of the techniques described by Talmage and 
Maurer (16) was used to study the precipitating capacity of antisera with I* M12, To 0.5 ml 
aliquots of serial dilutions of antisera was added 0.5 mi of I* M12 antigen.  The tubes were 
incubated at 4°C for 6 days, centrifuged at 2000 R.P.~.  for one hour, decanted and the pre- 
cipitated radioactivity measured. Because of the chemical impurity of the antigen used it was 
not possible to make quantitative determinations in terms of the amount of antigen nitrogen 
precipitated by a given amount of antiserum, but it was possible  to compare the precipitin 
reaction and the ammonium sulfate technique in terms of the relative capacities for measuring 
the anti NI protein activity of antisera. 
Capillary Precipitin Test.--The method described by Swift et al. (17) was used. Readings 
were taken after incubation for 24 and 48 hours at 4°C and measured according to the criteria 
suggested by these authors. 
Agar Precipitin  Test.--A modification of the Ouchterlony technique as described by Halbert 
(18)  was used. The wells were 7 mm in diameter, and the distance between the center well 
and the peripheral wells was 14 ram. Undiluted antisera and antigen in 0.3 ml quantities were 
routinely used. Observations were made every other day for 14 days. 
RESULTS 
Antigenic Nature of I* MIs.--To determine whether the iodination procedure 
or the subsequent attempts to purify the antigen had denatured or significantly 
altered  the  properties  of the  antigen,  capillary precipitation  and  Ouchterlony 
agar precipitation  tests  were  performed  on  the  acid  extract  before iodination 
and  on  the  iodinated  test  antigen  in  its  most  concentrated  form.  As  seen  in 
Table  I,  capillary  precipifin  tests  gave  good  reactions  with  homologous  type 
12  antisera  which  had  been  absorbed  twice with  a  type  17  streptococcus  and 
negative results  with similarly absorbed  antisera directed against  heterologous 
organisms.  The  results  were  essentially  the  same  whether  i0dinated  or unio- 
dinated  acid extract  was  used  as  the  antigen.  The  differences in  the intensity 674  ~f PROTEIN-ANTI-M~  PROTEIN  BINDING 
of the reactions were due to the fact that the iodinated M12 antigen used was 
one=tenth  as  concentrated  as  the  "purified"  uniodinated  extract  because  of 
dilution  occurring  in  the  process of iodination.  Agar diffusion plates  yielded 
parallel results in that after absorption of antisera with heterologous strepto- 
cocci,  the iodinated  antigen and crude acid extract reacted  to form bands  of 
precipitation with homologous antiserum only. Also,  the I* M~ used in these 
experiments  was  sufficiently free  of non-type-specific antigen  so  that  when 
tested by these two methods with unabsorbed heterologous antiserum, no pre- 
cipitation was observed. 
Binding of I* M12 by Streptococcal Antisera.--The  insolubility  of  I* M12- 
globulin complexes in 40 per cent SAS as compared to the solubility of the un- 
TABLE  I 
Capillary Precipitin  Tests Performed with Iodinated  and  Uniodinated Antigen 
Crude acid extract ......... 
~'Purified"  extract  prior  to 
iodination*.. 
[* M1s* 
Unabsorbed antisera (types) 
+++ 
++++ 
+++ 
14 
++ 
++ 
0 
Hetero- 
logous 
33  multi- 
valent 
++  ++++ 
+++  ++++ 
0  0 
Absorbed  anfisera  (types) 
Hetero- 
12  14  33  logous  multi- 
valent 
++  0  o  o 
++  o  0  o 
++  o  0  0 
* In the process of iodination, the antigen was diluted to one-tenth the concentration of 
the "purified" uniodinated extract. 
bound antigen at this salt concentration was used to measure the anti-type 12 
antibody  activity  in  a  serum.  Five-tenths  milliliter  of  I*  M12  antigen  was 
added to 0.5 ml aliquots of serial dilutions of unabsorbed antiserum. Mter in- 
cubation for 18 hours at 4°C  4, 1 ml of 80 per cent SAS was added to bring the 
final  concentration  of  ammonium  sulfate  to  40  per  cent.  This  mixture  was 
allowed to stand at 4°C for one-half hour before centrifugafion at 2000 ~.P.M. 
for 30 minutes. Mter centrifugation,  the supernatant fluid was discarded,  the 
precipitate washed in 3  ml of 40 per cent  SAS,  recentrifuged,  decanted,  and 
assayed for radioactivity. Fig.  1 A illustrates  the results obtained with unab- 
sorbed  hyperimmune  homologous  and  heterologous  antisera  when  per  cent 
radioactivity precipitated is plotted against antiserum dilution. The important 
points to be noted are:  (a)  the baseline precipitability of the antigen in  1:10 
NRS was 11 per cent; (b)  with 0.05 ml of anti-type 12 antiserum 51 per cent 
4 4oc is the standard temperature used for incubation,  salting out, and centrifugation in 
these studies. The per cent saturation of ammonium sulfate solutions refers to per cent satura- 
tion at 4°C. aOWARD ~r.  G~Y  675 
of the radioactivity was precipitated in 40 per cent SAS; (c) antibody was de- 
tected with as little as 0.00008 ml of antiserum; (d) with 0.05 ml of unabsorbed 
hyper~mmune heterologons type antiserum 27 per cent of the radioactivity was 
precipitated in 40 per cent SAS. 
In  an  attempt  to  decrease heterologous binding,  the  same  experiment as 
described above was performed on absorbed antiserum. Ilyperimmune heterolo- 
gous antiserum and hyperimmune anti-type 12 antiserum was absorbed with a 
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FIG. 1. Binding  of I* MI~ with antiserum directed against type 12 streptococci  and heter- 
ologous streptococci  utilizing absorbed and unabsorbed antiserum. 
mixture of type 1 and type 14 heat-killed organisms. One milliliter of packed 
bacterial sediment was used to absorb  10 ml of a  1:10 dilution of antiserum. 
Each absorption was carried out for 8 hours at 4°C  and centrifuged at 2500 
mp.~r,  for  30  minutes.  One  absorption  was  performed  on  the  heterologous 
antiserum and  three successive absorptions  on the homologous anti-type  12 
antiserum. Figure 1 B  represents the precipitation of I* M12 with these sera 
after the addition of 40 per cent SAS.  Whereas one absorption was sufficient 
to totally eliminate the precipitation caused by heterologons antiserum, three 
successive absorptions of the homologous antiserum left sufficient antibody so 
that increased precipitability of I* MI~ was still observed with a 0.0004 ml of 
antiserum. 
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sera.--Hyperimmune  absorbed rabbit anti-type 12 antiserum and an absorbed 
antiserum from a  human with rheumatic fever whose serum conferred mouse 
protection against 2000 times an LD6o dose of type 12 streptococcus  5 were used 
for this experiment. Five-tenths milliliter aliquots of serial dilutions of antisera 
were added to 0.5 ml of I* MI2. One set of aliquots was used for ammonium 
sulfate precipitation and one set was incubated at 4°C for 6 days and tested 
for spontaneous precipitation as described previously. The results comparing 
the two methods of antibody measurement are shown in Fig. 2. While both anti- 
sera showed excellent antibody responses as measured by the ammonium sulfate 
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FIG. 3. Type-specific  inhibition of I* Mlr-anti-Mn binding by streptococcal ceils and 
add extracts. 
technique, only the rabbit antiserum had any detectable spontaneous precipitin 
reaction. 
Type Specific Inhibition of I* Ml~anti-Mu Binding by Heat-Killed Strepto- 
cocci and Acid Extracts.--Uulabeled homologous M  protein added to a mixture 
of I* M12 and anti-type 12 antiserum in the zone of antigen excess should com- 
pete with and inhibit the complexing of I* Mx2 by anti-Mu sites. Under these 
conditions  the  extent of  the  inhibition  of  the  binding  between  I*  M12  and 
anti-M12  should be proportional to the quantity of unlabeled Mx~ present; and 
furthermore, unlabeled heterologous antigens should not inhibit this binding of 
I* M12 to its antibody. To test these propositions, 0.5 ml aliquots of a concen- 
6 Mouse  protection tests were kindly performed  by Dr. A. I. Braude. 678  M  PROTEIN-ANTI-M PROTEIN BINDING 
tration of type 12 antiserum, which would bind approximately 35 per cent of 
the I* Mn was added to 0.5  ml aliquots of serial dilutions in  1:20  NRS  of 
uniodinated acid extracts or whole heat-killed streptococci. Mter 2 hours at 
room temperature, 0.5 ml of I* M12 was added, the mixture allowed to incubate 
overnight at 4°C, and the procedure described above for precipitation of com- 
plexes with 40 per cent SAS carried out. Fig. 3 illustrates that (a) the inhibition 
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FIGS. 4 A and 4 B. Rates of dissociation  of I* Mid-anti-M12 complexes. Graph A represents 
the rate of dissociation of primary and secondary antiserum from a  single animal and graph 
B repersents the dissociation rates of antisera from two animals immunized and bled at the 
same time with the same streptococci in adjuvant mixture. 
of I* Mn-anti-Mn binding by Mn acid extracts and type 12 organisms was 
type-specific in that heterologous organisms did not inhibit this binding at all; 
and (b) extremely small quantities of type 12 organisms or type 12 acid extract 
were capable of totally inhibiting the binding between I* M12 and anti-Mn. 
DissociaEon of I* Mn-anti-Ml~ Complexes.--When equilibrium is established 
between unbound antigen and antibody and antigen-antibody complexes, asso- 
ciation and dissociation of complexes occur at equal rates. A means of distin- 
guishing between these two opposing processes  is necessary before it is possible 
to study effectively the dissociation of I* Mn-anti-Mn complexes.  This can be HOWAXD M.  O~Y  679 
accomplished  by  the  addition  of  a  large  excess  of  unlabeled  antigen  after 
equilibrium with isotopically labeled antigen is established, thereby making the 
relatively small  quantities  of I* M12 present insignificant in  terms of future 
association between antigen and antibody. Any subsequent dissociation could 
then  be  studied  and  would  be  manifested by a  decrease in  the  amount  of 
I* M12-globulin complexes precipitated upon addition of 40 per cent SAS as 
compared  to  the  amount precipitated under similar  conditions prior to  the 
addition of the unlabeled antigen. 
Five-tenths milliliter aliquots of I* M1, solution and type 12 antiserum were 
allowed to equilibrate overnight at 4°C in the region of antigen excess. To these 
mixtures were added 0.5 ml aliquots of unlabeled M12 extract at a concentration 
approximately 100 times that of the I* M12. This reaction mixture was incubated 
at 37°C, and at selected time intervals separate aliquots were precipitated with 
40 per cent SAS.  Fig.  4  illustrates  the curves obtained by plotting per cent 
dissociation 
I* in precipitate at time X -  I* in 1:10 NRS precipitate 
×  100 
I* in precipitate at time 0 -  I* in 1:10 NRS precipitate 
as a function of time after the addition of unlabeled antigen. As indicated by 
the steep slope of the first portion of each curve, some of the I* Mid-anti-M1, 
complexes dissociated  very rapidly.  The relative amounts  of this  quality of 
antibody varied in the serum obtained at different times during the course of 
immunization of animal 9-47 (Fig. 4 A) and during the course of immunization 
of all other animals similarly studied. Thus, 19 days after a single injection of 
heat-killed organisms, 50 per cent of the antigen-antibody complexes were dis- 
sociated  in  one  hour,  whereas  after  secondary stimulation  the  50  per  cent 
dissociation time was 21 hours. 
Just as the quality of antiserum produced varied within the same animal at 
different stages of immunization, variations between individual animals of the 
same species at the same stage of immunization have also been observed. Three 
monthly injections of heat-killed organisms in adjuvant were administered to 
each of five animals, and bleedings were taken one week after the last injection. 
As can be seen from the dissociation rate curves in Fig. 4 B  the variations in 
dissociability  of  I*  M~2-anti-M12  complexes between  the  two  animals  that 
showed the greatest variations in dissociation times was not as great as was ob- 
served between primary and secondary anfisera taken from the same animal. 
Considerable differences were observed, however, in that the 50 per cent disso- 
ciation time for the  antigen-antibody complexes formed from antiserum ob- 
tained from animal 10-28 was 5 hours, whereas the antiserum from animal 10-37 
had a 50 per cent dissociation time of 24 hours. The possible biological signifi- 
cance of these differences in the quality of antiserum produced will be discussed 
below. 680  M  PROTEIN-ANTI-M PROTEIN BINDING 
DISCUSSION 
The precipitation of antigen-antibody complexes in 40  per cent saturated 
ammonium sulfate was based on the work of Farr who studied a BSA-anti-BSA 
system (14).  In the BSA system, 50 per cent SAS was used to precipitate all 
of the antibody-bound BSA. However, due to the inherent insolubility of M 
protein at this salt concentration, it was necessary in the present study to use 
40 per cent SAS as the precipitating salt concentration. Not all globulins were 
precipitated at this concentration, however, and it is probable that under the 
conditions employed there were antigen-antibody complexes that remained in 
solution. In the BSA-anti-BSA system approximately 15 per cent of the antigen- 
antibody complexes formed in the region of antigen excess that were precipitable 
with 50 per cent SAS remained in solution when 40 per cent SAS was used as 
the precipitating salt concentration  (19).  Despite  this limitation, the  use of 
ammonium sulfate to precipitate antigen-antibody complexes yielded a system 
sufficiently  sensitive to detect the presence of antibody which was not detectable 
by the spontaneous precipifin reaction. 
The use of isotopically labeled antigen did not appear to affect the serologic 
characteristics of the antigen as determined by precipitin tests and did make 
possible the detection of extremely small quantities of antibody. A comparison 
between the capillary precipitin test and the precipitin reaction utilizing iso- 
topically labeled antigen serves  to illustrate  this point.  Whereas  a  600-fold 
dilution of a  hyperimmune antiserum yielded positive  results for anti-type 
12 antibody when I* MI~ was used as antigen (Fig. 2 A), a  tenfold dilution of 
the  same antiserum yielded negative results in  the  capillary precipitin  test. 
Although the sensitivity of the I* MI~ spontaneous precipitin test is slightly 
less  than  that exhibited by the  ammonium sulfate technique, it would still 
be a valuable method for the detection of anti-M12 antibodies, except for the 
considerable disadvantage that some sera having relatively large quantities of 
biologically active antibody, as measured by passive protection and the am- 
monium sulfate method, had little or no capacity to precipitate antigen spon- 
taneously (Fig. 2 B). This latter observation has been seen in other antigen- 
antibody systems (14)  and has been confirmed in the I* M12-anti-M12 system 
with several other human sera  and serves  to point up  the difficulty that is 
encountered in the evaluation of  results  obtained  from  any test  that  deals 
with secondary manifestations of antigen-antibody binding. 
In all measurements of anti-M protein antibody it is imperative to eliminate 
to as great an extent as possible non-type-specific antigen-antibody interaction 
that might be mistaken for M  protein-anti-M protein activity. This can be 
accomplished by either of two methods: (1) purification of the antigen so that 
M  protein  is  the  only antigen present;  (2)  absorption  of non-type-specific 
antibody from the antiserum. Both methods were used for the present study. 
The antigen was purified by incubation with heterologous antiserum and pre- HOWARD  ~.  GREY  581 
eipitation with ammonium sulfate to dispose of most of the antigen molecules 
capable  of binding  with  non-type-specific antibody.  The  antisera  were also 
purified by absorption with heterologous organisms.  The end result of these 
procedures was a test system which had no reactivity with absorbed heterol- 
ogons antisera  and  in which up to 50 per  cent  of the  radioactivity was spe- 
cifically precipitated by anti-type 12 antiserum. 
The  binding  exhibited  by unabsorbed heterologons  antiserum  and I* M12 
may have been due  to two mechanisms:  (1)  the presence of  contaminating 
non-type-specific antigen-antibody systems; (2) cross-reactivity between type 
12 M  protein and a  heterologous anti-M  antibody. As in other studies  that 
have involved this  antigen-antibody system (5, 8, 10, 20), it was not possible 
to determine with any certainty which of these mechanisms was operative. It 
appears likely that this particular problem will be solved only when M antigen 
is obtained in a chemically purified state. Until such time, however, it appears 
necessary  to  resort  to  heavy absorption  of  test  antisera  with  heterologous 
organisms  despite the possibility that biologicaUy  important  antibodies pro- 
duced against the M protein of one type may be removed by absorption with 
heterologous  organisms  due  to  cross-reactivity between  the  homologous  M 
protein  and  the heterologous M  protein used for absorption. 
Recent studies (21) utilizing  the bactericidal test and long chain reaction to 
detect M  protein have shown that  these tests can detect approximately 0.08 
and 0.3 #g of soluble M  protein respectively. In the I* Ml~-anti-M1,  system, 
0.005 gg of protein nitrogen or 0.03/~g  of protein was sufficient  to inhibit the 
reaction by 50 per cent (Fig. 3). This capacity to detect these small quantities 
of M protein may provide a useful tool in investigations concerned with study- 
ing the role of streptococcal antigens in the pathogenesis of tissue lesions seen 
in the non-suppurative complications of streptococcal infection. The I* MI~- 
anti-M~2 system can also be used to quantitate the M protein content on the 
surface of different strains  of streptococci. Preliminary studies from this lab- 
oratory indicate that equally virulent strains of type 12 streptococci may differ 
by several fold in the surface content of M protein. Also, an individual strain 
which has become avirulent by subculture onto artificial media may, on occa- 
sion,  contain more surface M  protein than  the virulent parent strain.  These 
results  add some evidence to the hypothesis that  although  the ability of an 
organism to produce M protein is probably a prerequisite for human or mouse 
virulence,  other undetermined  factors  must  also be operative before an  or- 
ganism can obtain maximal virulence (3). 
The  capacity  of  primary  binding  tests  to  yield  data  which  characterize 
quality as well  as quantity of antibody adds another parameter with which 
to study immune phenomena of M protein and its antibodies. The importance 
of this  aspect of the immune mechanism in terms of biological  function has 
been demonstrated by Jerne in the neutralization of diphtheria toxin by anti- 682  M  PROTEIN-ANTI-~[ PROTEIN BINDING 
toxin (22) and by Talmage (23) in the red cell-hemolysin complement systems. 
The possible role that the quality of the antibody to M  protein has on such 
biological phenomena as the type-specific protection of antisera against strepto- 
coccal infection and the production of acute glomerulonephritis in humans is 
under investigation. 
SUMMARY 
A method for detecting type-specific antibody to type 12/3-hemolytic strep- 
tococci is  described.  The  method  is  based  on  the  utilization  of  a  partially 
purified 1  TM labeled streptococcal acid extract and the solubility of this extract 
in 40 per cent saturated ammonium sulfate as compared to the insolubility of 
antibody and antigen-antibody complexes at this salt concentration. 
The  salient  features  of this  technique  are: 
(a)  When  absorbed  sera  were  used,  no  non-type-specific  reaction  with 
antigen occurred. 
(b)  The sensitivity of the system allowed detection of type-specific antibody 
in  hyperimmune antisera  that had been diluted  1200-fold. 
(c)  The method does not rely on secondary manifestations of antigen-anti- 
body interaction for the detection of antibody. 
(d)  As little as 0.03 #g of M12 protein was detected when soluble unlabeled 
M  protein was used to inhibit the reaction between 118~ M12 protein and anti- 
MI~ antibody. 
(e)  The kinetics of the reaction between M  protein and  anti-M  antibody 
can be studied, thereby making information available as to the quality as well 
as the quantity of antibody produced in this antigen-antibody system. 
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